Similar articles

• Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.

  DeSimone PA, Gams R, Bartolucci A. DeSimone PA, et al. Cancer Treat Rep. 1986 Jul;70(7):929-30. Cancer Treat Rep. 1986. PMID: 3521850 Clinical Trial. No abstract available.
• Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.

  Gams RA, Nelson O, Birch R. Gams RA, et al. Cancer Treat Rep. 1986 Jul;70(7):921-2. Cancer Treat Rep. 1986. PMID: 3521848 Clinical Trial. No abstract available.
• Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.

  Taylor SA, Von Hoff DD, Baker LH, Balcerzak SP. Taylor SA, et al. Cancer Treat Rep. 1984 Jun;68(6):919-20. Cancer Treat Rep. 1984. PMID: 6733708 Clinical Trial. No abstract available.
• Mitoxantrone (novantrone): a review of experimental and early clinical studies.

  Smith IE. Smith IE. Cancer Treat Rev. 1983 Jun;10(2):103-15. doi: 10.1016/0305-7372(83)90008-7. Cancer Treat Rev. 1983. PMID: 6347376 Review. No abstract available.
• New agents in non-small cell lung cancer.

  Joss RA, Cavalli F, Goldhirsch A, Mermillod B, Brunner KW. Joss RA, et al. Cancer Treat Rev. 1984 Sep;11(3):205-36. doi: 10.1016/0305-7372(84)90009-4. Cancer Treat Rev. 1984. PMID: 6395953 Review. No abstract available.